Intrinsic Imaging Undergoes Third FDA Inspection with No 483 Observations

Intrinsic Imaging recently underwent an extensive inspection by the U.S. Food and Drug Administration (FDA). The FDA determined Intrinsic Imaging was in complete compliance with all federal regulations and the company received zero 483 observations. This was Intrinsic Imaging's third FDA inspection and its third inspection with no findings. - March 01, 2021

Press Releases 1 - 1 of 1